Regulus Therapeutics Inc. (RGLS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 2.2700 |
| Open | 2.3000 |
| Bid | 2.4000 x 300 |
| Ask | 2.4200 x 100 |
| Day's Range | 2.2700 - 2.4800 |
| 52 Week Range | 1.0800 - 3.7900 |
| Volume | |
| Avg. Volume | 3,117,043 |
| Market Cap | 158.426M |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements
Financial and Clinical Progress Amidst Net Loss Wider Than Estimates
- Zacks
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
Amylyx Pharmaceuticals (AMLX) and Acadia Pharmaceuticals (ACAD) plunged on failure of studies.
- Zacks
Regulus (RGLS) Up 71% on Topline Data from Kidney Disease Study
Data from an early-stage study shows that treatment with Regulus' (RGLS) lead drug shows increased biological activity at a higher dose in patients with autosomal dominant polycystic kidney disease.
© 2024 Yahoo. All rights reserved.